Deploying a formal system for regulatory information management is a given now for all life sciences companies, irrespective of their size and focus. Regulators expect this, particularly as data rather than static documents evolves to become the default.
Colombia, one of the top three economies and most populous countries in Latin America, is a promising destination for medical device clinical trials for these reasons.
